A detailed history of Breakwater Capital Group transactions in Moderna, Inc. stock. As of the latest transaction made, Breakwater Capital Group holds 1,855 shares of MRNA stock, worth $135,229. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,855
Holding current value
$135,229
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$101.21 - $166.61 $187,744 - $309,061
1,855 New
1,855 $220 Million
Q1 2023

Apr 26, 2023

BUY
$135.66 - $197.02 $178,121 - $258,687
1,313 New
1,313 $202 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $28.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Breakwater Capital Group Portfolio

Follow Breakwater Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Breakwater Capital Group with notifications on news.